#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12880	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2513	630.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1934	1934	T	825	T,A	824,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12880	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2513	630.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1668	1668	C	811	C,A	809,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21276	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3985	664.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1934	1934	A	922	A,T,C	919,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21276	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3985	664.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2568	2568	C	705	C	705	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21276	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3985	664.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3194	3194	T	723	T	723	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21276	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3985	664.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2642	2642	A	655	A,T,C	651,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	G5V	NONSYN	13	15	GGT	481	483	GTT	112;111;111	G;T,C;T	112;110,1;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	E12K	NONSYN	34	36	GAA	502	504	AAA	118;119;120	A;A;A	118;119;120	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	F31L	NONSYN	91	93	TTT	559	561	TTG	145;146;149	T;T;G	145;146;149	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	592	594	CAA	171;170;172	C;A;A	171;170;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	S75P	NONSYN	223	225	TCC	691	693	CCT	146;150;149	C;C;T	146;150;149	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	V87A	NONSYN	259	261	GTA	727	729	GCA	116;117;117	G;C;A	116;117;117	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	V130L	NONSYN	388	390	GTC	856	858	CTC	180;183;184	C;T;C	180;183;184	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	R135C	NONSYN	403	405	CGC	871	873	TGT	183;184;184	T,G;G;T,G	182,1;184;183,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	T137A	NONSYN	409	411	ACG	877	879	GCG	179;182;180	G;C;G,T	179;182;179,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	919	921	AAG	197;195;196	A;A,C;G,A	197;194,1;195,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	T152N	NONSYN	454	456	ACC	922	924	AAT	197;198;196	A;A,G;T,G	197;197,1;195,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1120	1122	TTG	114;111;111	T;T;G	114;111;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1150	1152	AGC	108;107;110	A;G;C	108;107;110	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1219	1221	CTG	94;96;96	C;T,G;G	94;95,1;96	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1225	1227	TCC	96;97;97	T,G;C;C	95,1;97;97	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1240	1242	GTG	103;104;106	G;T,C;G	103;103,1;106	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1408	folP	852	852	93.78	folP.l15.c4.ctg.1	1907	92.0	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1291	1293	GCG	126;120;120	G;C,A;G	126;119,1;120	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4478	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3928	142.3	1	SNP	p	S91F	0	.	.	271	273	TCC	878	880	TCC	156;158;163	T,A;C;C,A	155,1;158;162,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4478	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3928	142.3	1	SNP	p	D95N	0	.	.	283	285	GAC	890	892	GAC	160;163;164	G;A;C	160;163;164	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4478	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3928	142.3	1	SNP	p	D95G	0	.	.	283	285	GAC	890	892	GAC	160;163;164	G;A;C	160;163;164	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1616	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1791	112.4	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	994	994	T	191	T	191	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	964	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1544	78.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1785	1787	ATC	217;215;218	A,C;T,C;C	215,2;214,1;218	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1938	1940	GCA	210;211;208	G,A;C,T;A	209,1;210,1;208	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	1	SNP	p	D86N	0	.	.	256	258	GAC	891	893	GAC	196;198;198	G;A,C;C	196;195,3;198	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	1	SNP	p	S87R	0	.	.	259	261	AGT	894	896	AGT	197;200;199	A,C;G,T;T,C	196,1;199,1;198,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	1	SNP	p	S87I	0	.	.	259	261	AGT	894	896	AGT	197;200;199	A,C;G,T;T,C	196,1;199,1;198,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	1	SNP	p	S87W	0	.	.	259	261	AGT	894	896	AGT	197;200;199	A,C;G,T;T,C	196,1;199,1;198,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4282	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3498	152.7	1	SNP	p	S88P	0	.	.	262	264	TCC	897	899	TCC	199;197;197	T,C;C;C	198,1;197;197	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3720	parE	1986	1986	99.95	parE.l15.c17.ctg.1	3148	147.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1835	1837	GGC	200;199;199	G;G;C,T	200;199;198,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1463	1465	GCA	192;194;195	G,A;C,G;A,C	191,1;193,1;194,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1466	1468	ATC	197;196;196	A;T;C	197;196;196	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1478	1480	GTG	187;187;185	G,T;T,G;G	186,1;186,1;185	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1478	1480	GTG	187;187;185	G,T;T,G;G	186,1;186,1;185	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1982	1984	ACC	199;200;200	A;C;C	199;200;200	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2036	2038	GCG	193;195;192	G,A;C;G	191,2;195;192	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2036	2038	GCG	193;195;192	G,A;C;G	191,2;195;192	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2159	2161	GGT	181;181;184	G;G;T,G	181;181;183,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2168	2170	GGC	179;180;182	G;G;C,G	179;180;181,1	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2874	151.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2186	2188	CCG	196;198;195	C,G,A;C;G	194,1,1;198;195	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4984	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3608	172.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2034	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2186	115.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	563	565	GGC	156;156;158	G;G;C,A	156;156;157,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2034	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2186	115.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	745	745	C	158	C	158	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	28;30;32	T;T;A	28;30;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	63;63;63	C;A;T,A	63;63;62,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	63;63;63	A;G;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	1;1;1	G;A;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	288	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	31.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2530	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1481	197.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	934	934	T	211	T	211	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2530	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1481	197.4	1	SNP	p	G120K	0	.	.	358	360	GGT	661	663	GGT	182;180;181	G;G;T,G	182;180;180,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2530	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1481	197.4	1	SNP	p	A121D	0	.	.	361	363	GCC	664	666	GCC	182;183;186	G;C,A;C	182;181,2;186	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2530	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1481	197.4	1	SNP	p	A121N	0	.	.	361	363	GCC	664	666	GCC	182;183;186	G;C,A;C	182;181,2;186	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8612	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5333	201.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2259	2261	CAT	210;209;208	C,T,A;A;T,C	208,1,1;209;207,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1268	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1571	100.5	1	SNP	p	V57M	1	.	.	169	171	ATG	809	811	ATG	219;217;218	A;T;G	219;217;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
